Back to Market返回行情

SOLV Solventum Corporation

USHealthcare
$76.70+0.97%ClosedMarket Cap: $13.28B

As of 2026-07-10 16:00

Why SOLV matters now

Solventum Corporation (SOLV) is a US stock in Healthcare. The latest InvestLog snapshot shows $76.70 with +0.97% on the session and $13.28B in market capitalization; recent performance reads 1-month +0.94% and YTD -4.81%.

The latest financial table shown here is Q1 2026, with revenue of $2.01B, net income of $13.0M, and EPS of $0.07. Investors can compare that operating picture with valuation signals such as P/E 6.97 and FCF yield -1.6%.

The latest indexable market news headline is "Solving A Lackluster Growth Outlook Should Be Solventum's Next Priority" from Seeking Alpha.

Additional event context on this page matters because analyst consensus is Hold with a median target of $92.00; recent insider activity includes Wilson Darryl L. filing A-Award; recent congressional disclosure data includes Ro Khanna Purchase. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

6.97

PEG

0.03

P/B

2.64

P/S

1.58

EV/EBITDA

6.38

DCF Value

$143.92

FCF Yield

-1.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

53.7%

Operating Margin

25.5%

Net Margin

17.3%

ROE

30.7%

ROA

10.2%

ROIC

15.9%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$2.01B$13.0M$0.07
Q4 2025$2.00B$63.0M$0.37
FY 2025$8.32B$1.56B$8.88
Q3 2025$2.10B$1.27B$7.22

Analyst Ratings

Consensus

Hold

Target (Consensus)

$84.29

Target (Median)

$92.00

Target Range

$43.00 - $100.00

Strong Buy: 1Buy: 6Hold: 6Sell: 2Strong Sell: 1
UBSNeutral
2026-05-06
StifelBuy
2026-05-06
BTIGBuy
2026-05-06
KeybancOverweight
2026-05-06
Wells FargoEqual Weight
2026-05-06

Trading Activity

Insider Trades

Wilson Darryl L.director
Sell2026-05-18
Wendell Amy McBridedirector
Sell2026-05-18
WEILAND JOHN Hdirector
Sell2026-05-18
Mily Elizabethdirector
Sell2026-05-18
MAY KAREN Jdirector
Sell2026-05-18

Congress Trades

Ro KhannaBuy
2026-06-11

Company Info

Sector

Healthcare

Industry

Medical - Care Facilities

Country

US

Exchange

Beta

0.75

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.